Uipath Inc (PATH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Uipath Inc stock (PATH) is currently trading at $10.93. Uipath Inc PE ratio is 21.29. Uipath Inc PS ratio (Price-to-Sales) is 3.67. Analyst consensus price target for PATH is $13.80. WallStSmart rates PATH as Moderate Buy.
- PATH PE ratio analysis and historical PE chart
- PATH PS ratio (Price-to-Sales) history and trend
- PATH intrinsic value — DCF, Graham Number, EPV models
- PATH stock price prediction 2025 2026 2027 2028 2029 2030
- PATH fair value vs current price
- PATH insider transactions and insider buying
- Is PATH undervalued or overvalued?
- Uipath Inc financial analysis — revenue, earnings, cash flow
- PATH Piotroski F-Score and Altman Z-Score
- PATH analyst price target and Smart Rating
Uipath Inc
📊 No data available
Try selecting a different time range
PATH Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Uipath Inc (PATH)
PATH trades at a significant discount to its Graham intrinsic value of $24.34, offering a 52% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Uipath Inc (PATH) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, eps growth, profit margin. Overall metrics suggest strong investment potential with favorable risk/reward.
Uipath Inc (PATH) Key Strengths (5)
Growing significantly faster than its price suggests
Earnings per share surging 107.40% year-over-year
75.08% of shares held by major funds and institutions
Strong profitability: $18 kept per $100 revenue
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Uipath Inc (PATH) Areas to Watch (5)
Premium pricing at 3.1x book value
Moderate profitability with room for improvement
Decent operational efficiency, solid but not exceptional
Revenue is fairly priced at 3.67x sales
Solid revenue growth at 13.60% per year
Uipath Inc (PATH) Detailed Analysis Report
Overall Assessment
This company scores 70/100 in our Smart Analysis, earning a B grade. Out of 10 metrics analyzed, 5 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 5.4/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on PEG Ratio, EPS Growth, Institutional Own.. Valuation metrics including PEG Ratio (0.41) suggest the stock is attractively priced. Profitability is solid with Profit Margin at 17.50%. Growth metrics are encouraging with EPS Growth at 107.40%.
The Bear Case
The primary concerns are Price/Book, Return on Equity, Operating Margin. Some valuation metrics including Price/Sales (3.67), Price/Book (3.10) suggest expensive pricing. Growth concerns include Revenue Growth at 13.60%, which may limit upside. Profitability pressure is visible in Return on Equity at 14.40%, Operating Margin at 16.60%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Book improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 14.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 13.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
The combination of PEG Ratio and EPS Growth makes a compelling case at current levels. The key risk is Price/Book, but the overall fundamental picture is positive with a clear path to maintaining or improving the current B grade.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PATH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PATH's Price-to-Sales ratio of 3.67x sits near its historical average of 3.88x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 11% below its historical high of 4.12x set in Mar 2026, and 0% above its historical low of 3.67x in Mar 2026.
Compare PATH with Competitors
Top SOFTWARE - INFRASTRUCTURE stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Uipath Inc (PATH) · TECHNOLOGY › SOFTWARE - INFRASTRUCTURE
The Big Picture
Uipath Inc is a mature, profitable business with steady cash generation. Revenue reached 1.6B with 14% growth year-over-year. Profit margins of 17.5% are healthy, with room for further expansion as the business scales.
Key Findings
Generating 179M in free cash flow and 182M in operating cash flow. Earnings are translating into actual cash generation.
Debt-to-equity ratio of 0.04 indicates a conservative balance sheet with 744M in cash.
What to Watch Next
Sector dynamics: monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive moves, and regulatory changes that could impact Uipath Inc.
Bottom Line
Uipath Inc is a well-established business delivering consistent profitability with 17.5% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Uipath Inc(PATH)
NYSE
TECHNOLOGY
SOFTWARE - INFRASTRUCTURE
USA
UiPath Inc. provides an end-to-end automation platform offering a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company is headquartered in New York, New York.